Mitch C. Hill - Mar 12, 2023 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role
Chief Financial Officer
Signature
/s/ Angela Ahmad, attorney-in-fact for Mitch C. Hill
Stock symbol
NARI
Transactions as of
Mar 12, 2023
Transactions value $
-$744,615
Form type
4
Date filed
3/14/2023, 07:05 PM
Previous filing
Feb 22, 2023
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Options Exercise $0 +125K +184.69% $0.00 193K Mar 12, 2023 Direct
transaction NARI Common Stock Options Exercise $2.97K +6.5K +3.36% $0.46* 200K Mar 13, 2023 Direct F1
transaction NARI Common Stock Sale -$34.1K -600 -0.3% $56.86 199K Mar 13, 2023 Direct F1, F2
transaction NARI Common Stock Sale -$75.5K -1.3K -0.65% $58.07 198K Mar 13, 2023 Direct F1, F3
transaction NARI Common Stock Sale -$271K -4.6K -2.32% $59.02 193K Mar 13, 2023 Direct F1, F4
transaction NARI Common Stock Sale -$34.1K -600 -0.31% $56.90 193K Mar 13, 2023 Direct F1, F5
transaction NARI Common Stock Sale -$99.1K -1.7K -0.88% $58.27 191K Mar 13, 2023 Direct F1, F6
transaction NARI Common Stock Sale -$233K -3.95K -2.07% $59.06 187K Mar 13, 2023 Direct F1, F7
holding NARI Common Stock 1.6K Mar 12, 2023 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NARI Restricted Stock Unit Options Exercise $0 -125K -100% $0.00* 0 Mar 12, 2023 Common Stock 125K $0.00 Direct F8
transaction NARI Stock Options (Right to Buy) Options Exercise $0 -6.5K -4.08% $0.00 153K Mar 13, 2023 Common Stock 6.5K $0.46 Direct F1, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022.
F2 This transaction was executed in multiple trades at prices ranging from $56.54 to $57.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $57.55 to $58.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $58.58 to $59.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $56.54 to $57.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 This transaction was executed in multiple trades at prices ranging from $57.66 to $58.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 This transaction was executed in multiple trades at prices ranging from $58.66 to $59.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F8 Amount represents the vesting in full of restricted stock units (RSUs) granted under the 2011 Plan in August 2019 that were subject to achievement of certain conditions specified in the award agreement, including continued service to the company. 100% of the RSUs vested on the fourth anniversary of the vesting commencement date as all conditions were satisfied.
F9 Options vested with respect to 25% of the shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment thereafter.